These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome--multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting. George AM; Meyers NL; Hickling RI Aliment Pharmacol Ther; 2008 May; 27(9):830-7. PubMed ID: 18284648 [TBL] [Abstract][Full Text] [Related]
10. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation. Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765 [TBL] [Abstract][Full Text] [Related]
12. Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial. Oduyebo I; Camilleri M; Nelson AD; Khemani D; Nord SL; Busciglio I; Burton D; Rhoten D; Ryks M; Carlson P; Donato L; Lueke A; Kim K; Rossi SJ; Zinsmeister AR Am J Gastroenterol; 2018 May; 113(5):725-734. PubMed ID: 29717197 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116 [TBL] [Abstract][Full Text] [Related]
14. Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation - a double-blind, randomized, placebo-controlled, study. Lembo AJ; Cremonini F; Meyers N; Hickling R Aliment Pharmacol Ther; 2010 May; 31(9):979-90. PubMed ID: 20163375 [TBL] [Abstract][Full Text] [Related]
15. Pilot study on the effect of linaclotide in patients with chronic constipation. Johnston JM; Kurtz CB; Drossman DA; Lembo AJ; Jeglinski BI; MacDougall JE; Antonelli SM; Currie MG Am J Gastroenterol; 2009 Jan; 104(1):125-32. PubMed ID: 19098860 [TBL] [Abstract][Full Text] [Related]
16. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Manabe N; Wong BS; Camilleri M; Burton D; McKinzie S; Zinsmeister AR Neurogastroenterol Motil; 2010 Mar; 22(3):293-e82. PubMed ID: 20025692 [TBL] [Abstract][Full Text] [Related]
17. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial. Acosta A; Camilleri M; Kolar G; Iturrino J; Szarka LA; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR; Spence SC; Gottesdiener K; Bouras EP; Vazquez-Roque MI Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2312-9.e1. PubMed ID: 26001337 [TBL] [Abstract][Full Text] [Related]
18. Linaclotide increases cecal pH, accelerates colonic transit, and increases colonic motility in irritable bowel syndrome with constipation. Farmer AD; Ruffle JK; Hobson AR Neurogastroenterol Motil; 2019 Feb; 31(2):e13492. PubMed ID: 30353623 [TBL] [Abstract][Full Text] [Related]
19. Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Manini ML; Camilleri M; Goldberg M; Sweetser S; McKinzie S; Burton D; Wong S; Kitt MM; Li YP; Zinsmeister AR Neurogastroenterol Motil; 2010 Jan; 22(1):42-9, e7-8. PubMed ID: 19691492 [TBL] [Abstract][Full Text] [Related]
20. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Cremonini F; Camilleri M; McKinzie S; Carlson P; Camilleri CE; Burton D; Thomforde G; Urrutia R; Zinsmeister AR Am J Gastroenterol; 2005 Mar; 100(3):652-63. PubMed ID: 15743365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]